Clinical development of targeted and immune based anti-cancer therapies | Journal of Experimental & Clinical Cancer Research | Full Text
![PDF] Opportunities and challenges of implementing Pharmacogenomics in cancer drug development | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/29715e53ee783cfda555fb4efebeaad13ace3874/6-Figure3-1.png "PDF] Opportunities and challenges of implementing Pharmacogenomics in cancer drug development | Semantic Scholar")
PDF] Opportunities and challenges of implementing Pharmacogenomics in cancer drug development | Semantic Scholar
Cancer drugs tested in clinical trials or under U.S. FDA review by... | Download Scientific Diagram
Emerging agents and regimens for cancer therapy
Clinical development of targeted and immune based anti-cancer therapies | Journal of Experimental & Clinical Cancer Research | Full Text
Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis - The Lancet Oncology
The Ten Most Promising Cancer Drugs Being Trialled
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations | Journal of Experimental & Clinical Cancer Research | Full Text
Innovative approaches for cancer treatment: current perspectives and new challenges - ecancer
Innovation in Oncology Drug Development
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Sanofi: Forging new paths in R&D for cancer treatments | Science|Business
The value of anticancer drugs — a regulatory view | Nature Reviews Clinical Oncology
Frontiers | Discovering Anti-Cancer Drugs via Computational Methods
Current Challenges in Cancer Treatment - Clinical Therapeutics
Overcoming cancer therapeutic bottleneck by drug repurposing | Signal Transduction and Targeted Therapy
Access to Experimental Cancer Drugs - NCI
Treatment Strategies in Cancer | Gene Therapy Network
Failed Cancer Clinical Trials: Why Most New Cancer Drugs Fail
How Are Cancer Drugs Discovered and Developed? | Cancer.Net
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations | Journal of Experimental & Clinical Cancer Research | Full Text
FDA approves a new cancer drug targeted to genetic mutation, not cancer type
Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review - The Lancet Oncology
Past, Present, and Future of Anticancer Nanomedicine | IJN
